medigraphic.com
ISSN 0035-0052 (Print)

2000, Number 3

<< Back Next >>

Rev Mex Pediatr 2000; 67 (3)

Bacterial meningitis: Current management

Coria LJJ, Espinoza OMM, Gómez BD

Language: Spanish
References: 42
Page: 133-141
PDF size: 444.40 Kb.


ABSTRACT

Until the introduction of sulfonamides and penicillins some 50-60 years age, the bacterial meningitis was in most cases a deadly disease. Since then it has become curable with a variable rate of morbidity and mortality in accordance with diferents pathogens (e.g. Streptococcus pneumoniae, Haemophilus influenzae type b, Neisseria meningiddis, Streptococcus of the group B, Escherichia coli, Pseudomonas spp., Staphylococcus aureus and epidermidis), and type of patients (neonates, infants and children, immunosuppressed, neurosurgical, skull trauma, and adult or elderly). Following the first lumbar puncture performed by Quincke in 1891 and the first identification of the pathogen by Heubner in 1896, an enormous number of clinical and therapeutic studies are been published. Nevertheless of that is still very difficult the evaluation of a patient with bacterial meningitis suspect and as well when institute antibiotic therapy.


REFERENCES

  1. McCraken HG Jr. Current management of bacterial meningitis in infants and children. Pediatr Infect Dis J 1992; 11: 169-174.

  2. López LP, Gómez BD, Sequeira SM, Moreno MJ. Actualidades en meningitis bacteriana. Infectología 1990; 10(2): 75-89.

  3. Philips FC. Epidemiology of bacterial meningitis. Pediatr Am 1994; 23(2): 67-68.

  4. Gómez BD, Jimémez VA, Rodríguez SR. Meningitis bacteriana. Parte 1. Bol Med Hosp Infant Méx 1998; 5(10): 599-622.

  5. Murray CJL, López AD. Global Health Statistics. A Compendium of incidence, prevalence and mortality estimates for over conditions. Vol II Harvard University Press 1996.

  6. Salih MA, Khaleefa OH, Bushara M et al. Long term sequelae of childhood acute bacterial meningitis in a developing country. Scand J Infect Dis 1991; 23: 175-182.

  7. Committee on Infectious Diseases/AAP. Therapy for Children with Invasive Pneumococcal Infection. Peditrics 1997; 99(2): 289-299.

  8. Hussey G. The management of bacterial meningitis in developing countries-issues of antibiotic therapy. Report to WHO Meeting, geneva 1997: 17-20.

  9. Center for disease control. Progress toward elimination of Haemophilus influenzae type b disease among infants and children in the United States 1987-95. MMWR. 1996; 45(42): 901-906.

  10. Adams WG, Deaver KA, Cochi SL et al. Decline in childhood Haemopphilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA 1993; 269: 221-226.

  11. Sáes-Llorens X, Ramilo O, Mustafa M, Mertsola J, McCracken GH Jr. Molecular pathophysiology of bacterial meningitis: current concepts and therapeutic implications. J Pediatr 1990; 116: 671-684.

  12. Tunkle AR, Wispelwey B, Scheldl WM. Bacterial meningitis: recent advances in pathophysiology and treatment. Ann Intern Med 1990; 112: 610-623.

  13. Wientzen RL, McCracken GH Jr. Pathogenesis and management of neonatal sepsis and meningitis. Curr Probl Pediatr 1977;

  14. 8: 3-61.

  15. Gladstone Mi, Ehrenkraz RA, Edberg SC, Baltimore RS. A ten-year review of neonatal sepsis and comparison with the previous fifty-year experience. Pediatr Infect Dis J 1990; 9: 819-825.

  16. Solorzano SF, Echaniz AG, Conde GC, Conde Glez CJ, Calderon JE, Arredondo Garcia JL, Beltran ZM. Cervicovaginal carriage of group B streptococci among Mexican women. J Infect Dis 1989; 159: 1003-1004.

  17. Davey PG, Cruikshank JK, McManus IC et al. Bacterial meningitis: Ten years’ experience. J Hyg 1982; 89: 383-401.

  18. Istre GR, Tarpay M, Anderson M, Pryor A, Welch D. Pneumococcus study group: Invasive disease due Streptococcus pneumoniae in area with a high rate of relative penicillin resistance. J Infect Dis 1987; 156: 732-735.

  19. Wubbel L, McCracken GH Jr. Management of bacterial meningitis 1998. Pediatrics in Review 1998; 19(3): 78-84.

  20. Feigin DR, McCracken GH Jr, Klein OJ. Diagnosis and management of meningitis. Pediatr Infect Dis J 1992; 11(9): 785-814.

  21. Saez-Llorens X, McCracken GH Jr. Bacterial meningitis. In: Katz SL, Gershon AA, Hotez PJ, eds. Krugman’s Infectious Diseases of Children. St. Lous, Mo: CV Mosby 1998: 265-279.

  22. Kline MW. Review of recurrent bacterial meningitis. Pediatr Infect Dis J 1989; 8: 630-634.

  23. Peltola H, Antilla M, Renkonen OV. Randomized comparison of chloramphenicol, ampicilin, cefotaxime and ceftriaxone for childhood bacterial meningitis. Lancet 1989; 1: 1281-1287.

  24. Kacica AM, Lepow LM. Meningitis: Clinical Presentation and Workup. Pediatr Ann 1994; 23(2): 69-75.

  25. Stutman HR, Marks MI. Bacterial meningitis in children: diagnosis and therapy. Clin Pediatr 1987; 26:431-438.

  26. Bonadio AW. The cerebrospinal fluid: physiologic aspects and alterations associated with bacterial meningitis. Pediatr Infect Dis J 1992; 11(6): 423-432.

  27. Radetsky M. Duration of treatment in bacterial meningitis: a historical inquiry. Pediatric Infect Dis 1990; 9: 2-9.

  28. Wood JAJ. Treatment of bacterial meningitis. N Engl J Med 1997; 336(10): 709-716.

  29. Paris MM, Hickey SM, Uscher MI, Shelton S. Olsen KD, McCraken GH Jr. Effect of dexametaxone on therapy of experimental penicillin-and cephalosporin-resistan pneumococcal menigitis. Antimicrob Agents Chemother 1994; 38: 1320-1324.

  30. Difabio JL, Homma A, DeQuadros C. Pan American Healh Organization Epidemiological Surveillance Network for Streptococcus pneumoniae. Microb Drug Resis 1997; 3(2): 131-157.

  31. Schaad UB, Suter S, Gianella-Borradori A et al. A comparison of ceftriaxone and cefuroxime for treatment of bacterial meningitis in children. N Engl J Med 1990; 322: 141-147.

  32. Klein OJ. Antimicrobial treatment and prevention of meningitis. Pediatr Ann 1994; 23(2): 7681.

  33. American Academy of Pediatrics. Red Book report of the committee on Infectious Diseases. 24th Edition. AAP 1997: 410-419.

  34. Viladrich PF et al. Four days of penicillin therapy for meningococcal meningitis. Arch Intern Med 1986; 146: 2380-2382.

  35. Macfarlane JT et al. Single injection treatment of meningococcal meningitis I. Long-acting penicillin. Trans Royal Soc Trop Med Hygiene 1979; 73: 693-97.

  36. Sakata Y, McCraken G, Thomas ML, Olsen KD. Pharmacokinetics and therapeutic efficacy of imipenem, ceftazidime, and ceftriaxone in experimental meningitis due to an ampicilin and chloramphenicol-resistant strain of Haemophilus influenzae type b. Antim Agents chemo 1984; 25(1): 29-32.

  37. Ngu JL, Youmbissi TJ, Mbanya C. Short-duration ceftriaxone versus ampicillin and chloramphenicol in the treatment of bacterial meningitis in children in Yaounde. XIXth Int Congr Pediatr, Paris 1986, abstr 301. Munich, Futuramed 1986.

  38. Lin T-Z, Chrane DF, Nelson JD, McCracken GH. Seven days of ceftriaxone therapy is as effective ten en day’s treatment for bacterial meningitis. JAMA 1985; 253: 3559-3563.

  39. Girgis NI et al. Intramuscular ceftriaxone versus ampicillin-chloramphenicol in childhood bacterial meningitis. Scand J Infect Dis 1988; 20: 613-617.

  40. Martin E et al. Short course single daily ceftriaxone monotherapy for acute meningitis in children. Results of a Swiss multicenter study. Infection 1990; 18(2): 70-77.

  41. Litsar I et al. ¿Five days of antibacterial therapy for bacterial meningitis in children? Infection 1995; 23(2): 113-118.

  42. Kornelisse RF et al. Pneumococcal meningitis in children: prognostic indicators and outcome. Clin Infect Dis 1995; 21: 1390-1397.




2020     |     www.medigraphic.com